Stoxline.com

Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations  |  Forex Crypto

Amneal Pharmaceuticals Inc (AMRX)

5.21   -0.21 (-3.87%) 10-23 23:45
Open: 5.43 Pre. Close: 5.42
High: 5.51 Low: 5.16
Volume: 947,392 Market Cap: 769M
Amneal Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development, manufacture, market and distribution of generic pharmaceutical products. The company is headquartered in Bridgewater, New Jersey and currently employs 6,000 full-time employees. The firm is engaged in the development, manufacture and marketing of bioequivalent pharmaceutical products (generics), in addition to the development and marketing of branded products. The company operates in two segments, which include Generics and Specialty Pharma. The Generics is focused on the development, manufacture, sale and distribution of the Company's generic products, which are the pharmaceutical and therapeutic equivalents of brand-name drug products and are marketed under their drug names. The Specialty Pharma is engaged in the promotion, sale and distribution of several branded products, including its branded pharmaceutical product, Rytary, an extended release oral capsule formulation of carbidopa-levodopa for the treatment of Parkinson's disease (PD), post-encephalitic Parkinsonism and Parkinsonism, and Zomig (zolmitriptan) products, indicated for the treatment of migraine headaches.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 5.514 - 5.542 5.542 - 5.56
Low: 5.096 - 5.132 5.132 - 5.154
Close: 5.159 - 5.213 5.213 - 5.247

Technical analysis

as of: 2020-10-23 4:40:33 PM
Overall:       
Stoxline posted a SELL today, downgraded from higher rating. Downward movement to be expected.
Target: Six months: 6.44     One year: 7.52
Support: Support1: 4.43    Support2: 3.76
Resistance: Resistance1: 5.51    Resistance2: 6.44
Pivot: 4.86
Moving Average: MA(5): 5.26     MA(20): 4.63
MA(100): 4.46     MA(250): 4.16
MACD: MACD(12,26): 0.32     Signal(9): 0.25
Stochastic oscillator: %K(14,3): 86.87     %D(3): 85.97
RSI: RSI(14): 68.07
52-week: High: 5.79  Low: 2.40  Change(%): 62.8
Average Vol(K): 3-Month: 114214  10-Days: 124169

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and NEUTRAL in mid-long term.
AMRX has closed below upper band by 27.8%. Bollinger Bands are 60% wider than normal. The large width of the bands suggest high volatility as compared to AMRX's normal range. The bands have been in this wide range for 8 bars. This is a sign that the current trend might continue.

Headline News

Fri, 23 Oct 2020
How Will the Market React to Amneal Pharmaceuticals Inc (AMRX) Stock Getting a Bullish Rating - InvestorsObserver

Thu, 22 Oct 2020
SVB Leerink Weighs in on Amneal Pharmaceuticals, Inc.'s Q3 2020 Earnings (NYSE:AMRX) - MarketBeat

Thu, 22 Oct 2020
A Look At The Behavior Of Amneal Pharmaceuticals, Inc. (AMRX) Stock - Stocks Register

Wed, 21 Oct 2020
Is Amneal Pharmaceuticals Inc. [AMRX] Stock Is Still Just for Futuristic Bulls at this Point? - MZP News

Wed, 21 Oct 2020
Do Analysts Expect Amneal Pharmaceuticals Inc (AMRX) Stock to Rise? - InvestorsObserver

Wed, 21 Oct 2020
Is Amneal Pharmaceuticals Inc. (AMRX) a Keeper? - The News Heater

Financial Analysis

Growth
Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Price to Book Value: Outperform Discounted cash flow: Outperform
Return on Assets: Neutral Price to Earnings: Underperform
Return on Equity: Neutral Debt to Equity: Outperform
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NYSE
Sector:  Healthcare
Industry:  Drug Manufacturers General Specialty & Generic
Shares Out. (M) 148
Shares Float (M) 94
% Held by Insiders 10.36
% Held by Institutions 69.44
Shares Short (K) 7,510
Shares Short P. Month (K) 6,920

Stock Financials

EPS -1.371
EPS Est This Year
EPS Est Next Year
Book Value (p.s.) 2.080
Profit Margin -11.16
Operating Margin 6.85
Return on Assets (ttm) 1.8
Return on Equity (ttm) -58.4
Qtrly Rev. Growth 14.8
Gross Profit (p.s.) 3.368
Sales Per Share 11.793
EBITDA (p.s.) 2.325
Qtrly Earnings Growth
Operating Cash Flow (M) 317
Levered Free Cash Flow (M) 213

Stock Valuations

PE Ratio -3.80
PEG Ratio
Price to Book value 2.50
Price to Sales 0.44
Price to Cash Flow 2.42

Stock Dividends

Dividend
Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
android_stock_chart
Stock Chart
stoxline_lite
Stoxline Lite
stoxline_pro
Stoxline Pro
Option_Calculator
Option Calculator
(c) 2006-2020 Stoxline.com | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Stoxline.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Stoxline.com web site, a user agrees not to redistribute the information found therein.